Sudarshan Pharma Industries

29.50
+0.40
(1.37%)
Market Cap
709.90 Cr
EPS
4.76
PE Ratio
39.33
Dividend Yield
0.00 %
Industry
Chemicals
52 Week High
53.50
52 Week Low
7.71
PB Ratio
5.40
Debt to Equity
0.65
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%

Company News

View All News
Caret
positive
Sudarshan Pharma's board has approved fundraising of up to 15 billion rupees. The company also plans to establish a wholly-owned subsidiary in the United States named Sudarshan Industries LLC. This new entity will focus on manufacturing and trading of chemical, pharmaceutical, and FMCG products.
positive
Sudarshan Pharma: Board Approves Rs 1,500 Crore Equity Raise3 days ago
Sudarshan Pharma Industries Ltd.'s board has approved raising Rs 1,500 crore through equity issuance via public issue, QIP, or private placement. The shares will have a face value of Rs 1 each and will be issued in one or more tranches, subject to stakeholder approval.
positive
Sudarshan Pharma Board Approves Fundraising of Up to 15 Billion Rupees3 days ago
Sudarshan Pharma's board has approved a fundraising initiative of up to 15 billion rupees. The news article does not provide any additional details about the method of fundraising, the purpose of the funds, or the timeline for this initiative.
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,235.20
#1 9,705.30
68.12
#1 2,555.90
#1 10.81
#1 357
-96.58
60.52
584.40
3,251.00
#1 12.26
957.90
1.00
133
-781.25
42.21
502.00
1,469.20
19.58
571.00
0.51
58
55.96
48.63
586.15
1,352.90
29.04
799.40
3.58
41
168.75
48.71
305.90
989.20
16.90
736.90
6.49
37
25.95
50.26
67.78
853.60
43.44
1,419.40
-10.50
7
625.00
36.34
180.51
787.80
19.54
511.20
1.17
19
135.94
47.93
29.50
#8 709.90
#7 39.33
#8 466.10
#7 0.80
#8 12
#8 20.48
45.24
233.20
663.70
208.77
165.20
2.35
-6
480.00
65.01
415.65
489.90
25.00
429.00
-15.95
16
#1 666.67
47.70
Forecast
Actual
Growth Rate
Revenue Growth
0.80 %
Net Income Growth
64.29 %
Cash Flow Change
120.88 %
ROE
47.06 %
ROCE
51.26 %
EBITDA Margin (Avg.)
59.36 %

Quarterly Financial Results

Quarterly Financials
Mar 2024
Dec 2024
Mar 2025
Revenue
232
229
279
Expenses
217
212
256
EBITDA
15
17
23
Operating Profit %
6 %
7 %
8 %
Depreciation
1
1
1
Interest
6
8
8
Profit Before Tax
9
8
14
Tax
2
2
4
Net Profit
7
6
10
EPS in ₹
0.27
0.25
0.42

Balance Sheet

Balance Sheet
2021
2022
2023
2024
Total Assets
99
138
233
283
Fixed Assets
6
7
20
26
Current Assets
88
130
199
242
Capital Work in Progress
0
1
0
2
Investments
0
0
0
2
Other Assets
93
131
213
254
Total Liabilities
99
138
233
283
Current Liabilities
71
103
119
161
Non Current Liabilities
6
5
13
11
Total Equity
23
30
101
112
Reserve & Surplus
13
20
77
88
Share Capital
10
10
24
24

Cash Flow

Cash Flow
2020
2021
2022
2023
2024
Net Cash Flow
-2
0
-1
12
-12
Investing Activities
-3
-1
-2
-26
-6
Operating Activities
1
3
-4
-29
6
Financing Activities
-0
-2
4
66
-12

Share Holding

% Holding
Mar 2023
Sept 2023
Mar 2024
Sept 2024
Mar 2025
Promoter
57.39 %
57.39 %
57.39 %
57.39 %
57.39 %
FIIs
0.00 %
1.40 %
1.40 %
13.07 %
18.45 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
20.35 %
27.04 %
23.61 %
23.20 %
18.18 %
Others
22.26 %
14.16 %
17.59 %
6.33 %
5.98 %
No of Share Holders
2,785
983
913
787
1,212

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.3 0.00 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 4.05 0.00 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
12 Jun 2025 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
12 Jun 2025 29.98 31.22
24 Apr 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
24 Apr 2025 29.53 27.81
04 Feb 2025 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
04 Feb 2025 49.79 40.30
30 Sept 2024 SPLIT Split
1:10
23 Nov 2024 41.86 41.86
31 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
31 Oct 2024 35.30 38.48
30 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
30 Sept 2024 41.89 41.86
30 Sept 2024 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
30 Sept 2024 21.52 41.86
05 Feb 2024 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
05 Feb 2024 7.53 7.71
26 Aug 2023 DIVIDEND Dividend
₹ 0.30 /share
25 Aug 2023 6.75 8.15

Announcements

Announcement under Regulation 30 (LODR)-Acquisition3 days ago
Announcement under Regulation 30 (LODR)-Acquisition3 days ago
Announcement under Regulation 30 (LODR)-Issue of Securities3 days ago
Board Meeting Intimation for Meeting Of The Board Of Directors To Be Held On Thursday 19-June-20256 days ago
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report8 days ago
Shareholder Meeting / Postal Ballot-Outcome of EGM9 days ago
Proceedings Of Extraordinary General Meeting Held On 12Th June 202510 days ago
Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jun 04, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 29, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 29, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 17, 2025
Extraordinary General Meeting On 12/June/2025May 16, 2025
Announcement under Regulation 30 (LODR)-Updates on AcquisitionMay 13, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateMay 12, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationMay 02, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateMay 02, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationApr 26, 2025
Financial Results For The Financial Year Ended March 31 2025Apr 24, 2025
Board Meeting Intimation for Approval Of Financial Results On Thursday 24-04-2025Apr 21, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 21, 2025
Announcement under Regulation 30 (LODR)-Updates on AcquisitionApr 03, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateApr 01, 2025
Closure of Trading WindowMar 31, 2025
Change In Market Maker Of The CompanyMar 26, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 20, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateMar 06, 2025
Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)Mar 06, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 04, 2025
Announcement under Regulation 30 (LODR)-Updates on AcquisitionFeb 26, 2025
Announcement under Regulation 30 (LODR)-AcquisitionFeb 19, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportFeb 07, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportFeb 05, 2025
Shareholder Meeting / Postal Ballot-Outcome of EGMFeb 05, 2025
Proceedings Of Extraordinary General MeetingFeb 04, 2025
Corrigendum To Notice Of Extra-Ordinary General Meeting Dated 10-Jan-2025Jan 31, 2025
Announcement under Regulation 30 (LODR)-Issue of SecuritiesJan 31, 2025
Technology Transfer Agreement With Uttaranchal UniversityJan 25, 2025
Announcement under Regulation 30 (LODR)-AcquisitionJan 16, 2025
Premises Taken On Rent For Setting Up New Research & Development Formulation Centre In Dehradun Uttarakhand India - ClarificationJan 16, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 14, 2025
Extraordinary General Meeting On Tuesday February 4 2025Jan 13, 2025
Board Meeting Outcome for Preferential Issue Of WarrantsJan 10, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationJan 09, 2025
Premises Taken On Rent For Setting Up New Research & Development Formulation Centre In Dehradun Uttarakhand IndiaJan 07, 2025
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Friday January 10 2025Jan 06, 2025
Announcement under Regulation 30 (LODR)-AcquisitionNov 29, 2024
Announcement under Regulation 30 (LODR)-CessationNov 29, 2024
Shareholder Meeting / Postal Ballot-Scrutinizers ReportNov 21, 2024
Shareholder Meeting / Postal Ballot-Outcome of EGMNov 21, 2024
Addendum To The Notice Of The Extraordinary General Meeting Of Sudarshan Pharma Industries Limited Held On Monday, 30Th September, 2024Nov 18, 2024

Technical Indicators

RSI(14)
Neutral
45.24
ATR(14)
Less Volatile
0.82
STOCH(9,6)
Oversold
9.06
STOCH RSI(14)
Oversold
12.57
MACD(12,26)
Bearish
-0.29
ADX(14)
Weak Trend
15.63
UO(9)
Bearish
37.04
ROC(12)
Downtrend And Accelerating
-4.84
WillR(14)
Oversold
-81.47